<?xml version="1.0" encoding="UTF-8"?>
<ref id="pntd.0008102.ref028">
 <label>28</label>
 <mixed-citation publication-type="journal">
  <name>
   <surname>Ferguson</surname>
   <given-names>NM</given-names>
  </name>, 
  <name>
   <surname>Rodríguez-Barraquer</surname>
   <given-names>I</given-names>
  </name>, 
  <name>
   <surname>Dorigatti</surname>
   <given-names>I</given-names>
  </name>, 
  <name>
   <surname>Mier-Y-Teran-Romero</surname>
   <given-names>L</given-names>
  </name>, 
  <name>
   <surname>Laydon</surname>
   <given-names>DJ</given-names>
  </name>, 
  <name>
   <surname>Cummings</surname>
   <given-names>DAT</given-names>
  </name>. 
  <article-title>Benefits and risks of the Sanofi-Pasteur dengue vaccine: Modeling optimal deployment</article-title>. 
  <source>Science</source> [Internet]. 
  <year>2016</year>
  <month>9</month>
  <day>2</day> [cited 2017 Dec 18];
  <volume>353</volume>(
  <issue>6303</issue>):
  <fpage>1033</fpage>–
  <lpage>6</lpage>. Available from: 
  <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/27701113" xmlns:xlink="http://www.w3.org/1999/xlink">http://www.ncbi.nlm.nih.gov/pubmed/27701113</ext-link>
  <pub-id pub-id-type="doi">10.1126/science.aaf9590</pub-id>
  <?supplied-pmid 27701113?>
  <pub-id pub-id-type="pmid">27701113</pub-id>
 </mixed-citation>
</ref>
